Author | Kristina Frinzi Byers, PharmD, BCOP

Articles

Management of Neutropenic Toxicity From CDK4/6 Inhibitors

January 17, 2019

An oncology pharmacist discusses how to manage neutropenic toxicity from treatment with CDK4/6 inhibitors for HR-positive breast cancer.